BALTIMORE, June 30 /PRNewswire/ — GoIndustry DoveBid
announces the Pfizer asset disposition program, which will see
auctions of surplus assets from Pfizer’s facilities across the United States. Over 500 lots per
week will be available via online auction as part of GoIndustry
DoveBid’s ongoing BioPharma Exchange, over the upcoming months.
(Logo: http://photos.prnewswire.com/prnh/20100630/PH28915LOGO
)
(Logo: http://www.newscom.com/cgi-bin/prnh/20100630/PH28915LOGO
)
Each week’s auction will include an outstanding selection of
assets ranging from HPLC and NMR Systems to Mass Spectrometers and
general lab equipment. The majority of assets come from working
environments and have been maintained, as one would expect from a
top tier company such as Pfizer.
“With GoIndustry DoveBid, we have undergone an extensive
project to identify all the surplus assets in our facilities across
the country,” said Bill
Carr, Asset Disposition Director, from Pfizer Inc. “We
have been pleased with our past results and look forward to our
upcoming participation in the BioPharma Exchange.”
The GoIndustry DoveBid BioPharma Exchange is a weekly series of
online auction sales. Bu
‘/>”/>
